Acorda Therapeutics reported $-6199000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Agios Pharmaceuticals AGIO:US $ -95.35M 3.32M
ALKERMES ALKS:US $ -15.07M 7.68M
Amgen AMGN:US $ 3004M 337M
Aptinyx Inc APTX:US $ -17005000 2.27M
Arrowhead Research ARWR:US $ -70306000 114.46M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Cara Therapeutics CARA:US $ -4409000 23.44M
Clovis Oncology CLVS:US $ -57.48M 9.04M
Cytokinetics CYTK:US $ -9.47M 67.05M
Enanta Pharmaceuticals ENTA:US $ -31.82M 1.2M
Gilead Sciences GILD:US $ 2585M 837M
GlaxoSmithKline GSK:LN 244700M 1400M
Halozyme Therapeutics HALO:US $ 46.61M 29.84M
Insmed INSM:US $ -98081000 92K
Mannkind MNKD:US $ -23.55M 1.63M
Merck MRK:GR € 1791M 161M
Moderna Inc MRNA:US 2.52B 1.78B
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Teva Pharmaceutical TEVA:IT 1.09B 20M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M